The current TELO market cap is 123.22M. The company's latest EPS is USD -0.5555 and P/E is -7.79.
Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -138k | -854k | -3.94M | -12.24M |
Net Income | -138k | -854k | -13.07M | -16.53M |
Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 0 | 49k | 4.77M | 1.32M |
Total Liabilities | 138k | 986k | 1.34M | 681k |
Total Equity | -138k | -937k | 3.44M | 643k |
Market Cap | 123.22M |
Price to Earnings Ratio | -7.79 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 101.88 |
Price to Book Ratio | 200.42 |
Dividend Yield | - |
Shares Outstanding | 29.76M |
Average Volume (1 week) | 157.86k |
Average Volume (1 Month) | 134.68k |
52 Week Change | -53.48% |
52 Week High | 9.39 |
52 Week Low | 3.11 |
Spread (Intraday) | 26.11 (92.07%) |
Company Name | Telomir Pharmaceuticals Inc |
Address |
900 west platt street, suite 200 tampa, florida 33606 |
Website | https://www.telomirpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions